Materials and Methods
Mice. Adult mice of either sex from 6 wk to 6 mo of age were used in all experiments. All mice were bred in our facilities at the Mayo Clinic or Stanford University or purchased from The Jackson Laboratory (Bar Harbor, ME). The recombinant and mutant mice used were generously provided by Dr. Chella David, Mayo Medical School, Rochester, MN.
Culture Medium. Complete culture medium consisted of RPMI 1640 (Gibco Laboratories, Grand Island Biological Co., Grand Island, NY) containing 10% fetal calf serum (FCS), 5 × 10 -5 M 2-mercaptoethanol, 10 mM Hepes, 100 U/ml penicillin, and 100 pg/ml streptomycin. L-glutamine was added to a final concentration of 2 × 10 -~ M before use. The alloreactive clones in the 11 series, e.g., 11.17, were maintained and assayed in medium containing 10% horse serum instead of 10% FCS.
Cell Lines. The alloreactive cell lines were maintained as has been described previously (5) , except that cloned lines usually required the addition of 0.5-1% rat eoncanavalin A (Con A) supernatant factor when recultured every 10-14 d. The rat Con A supernatant factor was prepared as described (5) . The myoglobin-reactive clone 26.17 and the keyhole limpet hemocyanin (KLH) -reactive clones 9 and 11 have been described elsewhere (3, 4) .
Proliferation Assay. The [3H]thymidine incorporation proliferation assay was performed as described previously (5) . To test the ability of various antibody preparations to block the proliferative response, a small amount of antibody (~2.0 #g/well) was added to the appropriate wells in the standard assay system. Specificity of blocking was controlled by testing the same antibody against an inappropriate responder clone. k Antibodies. The monoclonal anti-I-A antibodies H150.13, Hl16.32, and Hl18.49 were described previously (6, 7). Antibody 10-2.16 was obtained from Dr. Vernon Oi, Stanford University (8) . Monoclonal antibodies were purified by affinity chromatography on protein A sepharose and brought to 1.0 mg/ml in phosphate-buffered saline. Two-dimensional Gel Analyses of Ia Molecules. Ia molecules were biosynthetically labeled and isolated as described previously (9) . Briefly, spleen cells were teased into a single-cell suspension and incubated with S-methionine (1 mCi/ml) for 5 h at 37°C in a solution consisting of methionine-free Dulbecco's modified Eagle's medium, 5% dialyzed FCS, and 10 mM Hepes. Cells were solubilized at ~2 × 10 v cells/ml in 0.5% Triton X-100, and cell debris removed by centrifugation. Extracts (usually 100 pl) were precipitated with either monoclonal antibodies or antisera, and the complexes were adsorbed to fixed Staphylococcus aureus bacteria. Precipitates were eluted directly into lysis buffer (9.5 M urea, 2% Triton X-100, 1.6% ampholines, pH 5-7, 0.4% ampholines, pH 3.5-10, and 5% 2-mercaptoethanol) and then analyzed by two-dimensional gel analysis as described (9) .
Results

Monoclonal Anti-I-A k Antibodies Block Proliferation of Alloreactive T Cell Clones.
We have previously described (1, 10) several alloreactive A anti-(B6A)F1 T cell clones with different spectra of reactivities against stimulator cells of various haplotypes. Among these is a group of clones that appear, by mapping experiments, to be specific for alloantigens that are controlled by the I-A region of the H-2 complex. Using monoclonal anti-Ia antibodies, we have studied the relationship between the I-A determinants recognized by the T cell clones and the I-A determinants recognized by alloantibodies.
In Table I we present data on the ability of four different anti-I-A k monoclonal antibodies to block the proliferative response of four alloreactive T cell clones to (B6A) F1 splenic stimulator cells. All of these alloreactive clones were obtained from A anti-(B6A)F1 bulk cultures by cloning either in soft agar or by limiting dilution (5). Clones 11.17, 1 I. 19, 10.39.2, and 23AB 1.2 are specific for I-Ak/I-A b hybrid molecules, which can be seen from the data presented in Table II . A similar clone, 1.8.16, has The response, as cpm of [3H]thymidine incorporation, on day 2 of 2 × 104 cloned responder cells to 1 × 106 irradiated (3,300 rad) stimulator cells. * The bml2 mouse has a mutation in the A¢ chain (16) . The response, as cpm of [~H]thymidine incorporated, on day 3 of 1 × 104 cloned responder cells to 3/IM myoglobin or 50/~g/ml KLH in the presence of 1 X 106 irradiated (3,300 rad) syngeneic spleen cells. * Not tested.
TABLE III
Inhibition of Antigen Recognition by Monoclonal Anti-I-A k Antibodies
been described previously (1, 1 1). The antibody-blocking data presented in Table I indicate that these four clones represent two different types. Clones 11. 17 We examined the I-A molecules precipitated by antibodies 10-2.16 and Hl16.32. Both of these monoclonal antibodies recognize spleen cells of haplotype k but not haplotype b (6, 8) . Assuming that the I-A a and fl polypeptides can freely associate in (BbA)F1 (b X k) cells and that antibodies reacting with one chain (e.g., a) will precipitate the corresponding chain ~) through noncovalent association, we sought to distinguish whether antibody Hl16.32 recognized the same molecular complex as 10-2. 16 b k (A,A~) or the reciprocal complex (A~A~. Our results are shown in Fig. 1 . Antibody H116.32 (Fig. 1 d) precipitates A~, A~, and A~ chains from (BbA)F1 spleen cells, as seen by comparison with molecules precipitated from the parental strain cells (Fig. 1 a, b, c) . This pattern indicates recognition k k k b of A~A~ and A~A~ molecules via a determinant on the A~ chain. Antibody 10-2.16, as previously reported (12), precipitates A k, A~, and A~ chains from (BbA)F1 spleen cells (Fig. 1 e) , which indicates recognition of k k b k A~At~ and A~Ap molecules'via the A~ chain. A mixture of I-A b and I-A k molecules precipitated separately is shown for comparison (Fig. 1 c) . In summary, our two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis data are most consistent with the interpretation that antibodies 10-2. (Tables III and IV) 
Discussion
We have previously (1, 3, 4, 17) presented data demonstrating that among the alloreactive and antigen-reactive T cell clones, we can differentiate those that recognize I-A and I-E region Ia molecules by mapping the loci controlling expression of the molecules. Although it was suspected that there were two possible hybrid molecules expressed in I-A region heterozygotes, on the basis of the two-chain nature of Ia molecules, the lack of recombinants within the I-A region did not permit their discrimination by mapping experiments. We therefore turned to using monoclonal anti-Ia antibodies to differentially block stimulation of the cloned cell lines.
In the past, there have been several reports on the ability of anti-Ia alloantisera to block stimulation of appropriate MLR (18, 19) . The interpretation of these experiments has been that the Ia molecules detected by the alloantisera are the determinants that stimulate the MLR. However, there always remained the possibility that the alloantisera contained antibodies for MLR-stimulating determinants that were distinct from Ia antigens, but were closely linked to them genetically. The recent production of monoclonal anti-Ia antibodies and isolation of T cell clones makes it possible to do similar experiments in a more clearly interpretable manner. We used several monoclonal anti-I-A k antibodies that had been produced and characterized previously (6) (7) (8) . We found that the ability of these antibodies to block the stimulation of I-Ak/I-Ab-reactive clones divided the clones into two groups. Based on the biochemical analysis, which showed that antibody 10-2.16 reacts with a determinant on the A~ chain (12), and our two-dimensional gel analysis, which confirmed this and showed that antibody H116.32 reacts with the Ak, polypeptide, we concluded that the F1-b k recognizing clones blocked by antibody 10-2.16 are reactive with the A~Aa hybrid molecule, whereas clones blocked by Hl16.32 are reactive with k b A~A~ molecules. Furthermore, we would argue that other antibodies that block proliferation of T cell clones in a pattern identical to that of 10-2.16 also recognize determinants on A~, whereas an H116.32-1ike blocking pattern characterizes antibodies reactive with the A~ polypeptide. We have preliminary data to suggest that this argument is correct. An independently derived anti-I-A k monoclonal antibody (provided by M. Pierres, Centre d'Immunologie, INSERM-CNRS, Marseilles, France), which blocks proliferation of clones exactly as 10-2.16 does, also immunoprecipitates the same I-A products. Also, we can infer that Ia specificity 17 (10-2.16) and the Ia.17-1ike specificity of H 150.13 are A~ determinants, whereas specificities 19 (H 116.32) and 2 (H 118.49) are related to the A~ chain. The functional data presented in this paper are in complete agreement with competitive antibody-binding studies (7) showing close proximity of binding sites for antibodies 10-2.16 and H150.13. These sites are distant from sites recognized by antibodies H 116.32 and H 118.49, which are, conversely, close to each other.
The mutant mouse strain B6.C-H-2 bm12 provides us with an additional line of evidence that MLR-stimulating determinants and restriction elements for antigen presentation are Ia molecules (11). The bm 12 mutant was originally discovered as a gain-and-loss spontaneous mutant by skin grafting (13) . By complementation studies, the mutation mapped to the I-A region, and later serological analysis demonstrated the absence of specificity Ia.8 and the reduction of specificities Ia.3, 9, 15, and 20 on spleen cells of bml2 mice (14, 15) . McKean et al. (16) , using tryptic peptide analysis, have recently found that the A~ m12 chain isolated from bml2 spleen cells differs from the normal B6 A~ chain. We examined whether cells from [bml2 × B10.A(4R)]F1 mice would express the MLR-stimulating determinants or antigen-presenting determinants recognized by the alloreactive or antigen-specific T cell clones used in this report. We predicted that certain clones that recognized the A~A~ molecule, as defined by the antibody-blocking experiments, would not respond to (Tables III and IV) .
We have provided biochemical, genetic, and functional evidence for discrimination k b b k of A~A~ vs. A~A~ hybrid I-A molecules by T cell recognition. Although the results of any one line of evidence are insufficient to unambiguously document this discrimination, the antibody-blocking data taken together with the biochemical data strongly suggest that these two separate hybrid molecules can serve as stimulating determinants or restriction elements for separate sets of T cell clones. These data and the additional line of evidence presented by studying antigen presentation using cells of the bml2 mouse unequivocally demonstrate that the two sets of clones are recognizing reciprocal combinations of alpha and beta A region polypeptides.
Summary
Alloreactive and soluble antigen-reactive, I-A-restricted T cell clones were examined for their ability to recognize hybrid I-A antigens. Several clones that recognized hybrid I-Ab/I-A k molecules on (C57BL/6 × A/J)F1 [(B6A)F1] spleen cells were studied. We were able to distinguish clones that recognized hybrid I-A molecules of the b k A,Aa type from those that recognized AkA~ molecules. We reached this conclusion by considering data from three independent types of experiments. [bml2 X B10.A(4R)]F1 cells use a recognition site(s) on A,A~ molecules. Thus, we can demonstrate both functionally and biochemically that hybrid F1 I-A molecules of the structure AkA~ and A~A~ both exist on (B6A)F1 splenocytes and that both configurations are used in immune recognition phenomena.
